Antacids containing aluminum, magnesium, or calcium dramatically reduce ciprofloxacin absorption, often rendering the antibiotic ineffective. This can lead to treatment failure and contribute to antibiotic resistance. The interaction is one of the most clinically significant absorption-related drug interactions.
How This Interaction Works (Mechanism)
Antacid metal cations (Al3+, Mg2+, Ca2+) form highly stable chelation complexes with ciprofloxacin's 3-carboxyl and 4-oxo groups. These complexes are essentially insoluble and cannot be absorbed from the GI tract. Antacids can reduce ciprofloxacin bioavailability by up to 85 to 90 percent, which almost certainly results in subtherapeutic drug levels. The interaction occurs rapidly in the acidic environment of the stomach.
Source: Cipro (Ciprofloxacin) Prescribing Information, Bayer, 2025
Do not take antacids within 2 hours before or 6 hours after ciprofloxacin. This includes Tums, Maalox, Mylanta, Rolaids, and similar products. If you need acid relief, ask your doctor about a proton pump inhibitor or H2 blocker, which do not chelate with ciprofloxacin. Also avoid sucralfate, iron supplements, and multivitamins with minerals during ciprofloxacin treatment.
Check More Drug Interactions
Use our free interaction checker to search thousands of drug, supplement, and food combinations.
Open Interaction CheckerKeep a multi-drug routine straight
As an Amazon Associate I earn from qualifying purchases.
Sources and standards behind this page
What a drug interaction does, and how strongly it is supported, is documented in public labeling and federal safety references rather than in any one summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- DailyMed carries the current FDA labeling for every marketed drug product, including the warnings and drug interaction sections.
- Drugs@FDA is the federal database of approved drug products and their approval documents.
- FDA: Drug interactions, what you should know explains how drug-drug, drug-food and drug-condition interactions are described on labels.
- FDA Drug Safety Communications publishes the agency's safety alerts and label changes as they are issued.
- FDA MedWatch is the program for reporting and reviewing adverse events, including suspected interactions.
- openFDA provides public access to FDA labeling and adverse event data.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medicine is and how it is taken.
- NIAAA: Harmful interactions documents which medicines interact with alcohol and how.
- NCCIH: Herb-drug interactions summarises the evidence on interactions between herbal products and medicines.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how this interaction works and where it is documented. It is not medical advice: a prescriber or pharmacist decides what applies to a particular patient and medication.
Frequently Asked Questions
Ciprofloxacin and Antacids have a severe interaction and should generally not be taken together without close medical supervision. The combination can cause serious, potentially life-threatening side effects. Contact your doctor immediately if you are currently taking both medications.
Antacids containing aluminum, magnesium, or calcium dramatically reduce ciprofloxacin absorption, often rendering the antibiotic ineffective. This can lead to treatment failure and contribute to antibiotic resistance. The interaction is one of the most clinically significant absorption-related drug interactions.
Yes. Anytime you are taking multiple medications, supplements, or substances, you should inform your doctor and pharmacist. They can evaluate your specific risk factors (age, kidney function, other medications, medical conditions) and determine whether the Ciprofloxacin and Antacids combination is safe for you, or whether adjustments are needed.
Related Resources
Get Drug Safety Alerts
Leave your email for updates on FDA warnings, new drug interactions, and patient safety information. We have not started sending yet, and we will only email when we do.